Search Results for: Buttermilk containing any sweetening matter
conditions on the sale of the biosimilar version of roche's breast cancer drug, trastuzumab, by biocon and mylan. before i delve into the findings of the single judge, i should point out that, as one of the commenters to my previous article noted, the decision has been stayed by a division bench and the matter
secret, the treaty has been controversial for adopting trip plus standards in ip, threatening internet freedom, endangering the rights of labour, health and the environment, and, largely furthering... read more " data exclusivity drug regulation uncategorized data exclusivity: ipa letter to min opposes any...
https://spicyip.com/category/data-exclusivity